Pharmafile Logo

Latest European developments and new talent at Research Partnership

March 19, 2024 | Careers, Growth, New hires 

- PMLiVE

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its evolution into a global organization and forming part of Inizio Advisory. Her outstanding contributions to the company’s growth and expansion has led to her well-earned appointment to this new position. Angela will now spearhead the strategic growth of our European teams, ensuring our clients receive high quality insights and solutions to their business challenges.

In addition, Grzegorz Stanczyk has joined Research Partnership as Operations Director, having previously worked at Hall and Partners. With a wealth of experience in operational strategy within the market research industry, Grzegorz will play a pivotal role in supporting our ad-hoc research teams and overseeing our Compliance and Commercial Affairs functions. His expertise in client and supplier contracting, as well as MSA negotiations, will help to enhance our operations.

Helen Cox has joined the business as Senior Commercial Director. Helen is an accomplished insights professional with over 25 years’ experience, having led client engagement across healthcare clients in her most recent role at Ipsos, both in defining the overall strategy and leading client accounts. Helen brings a wealth of experience in strengthening client partnerships, understanding clients’ businesses, and bringing the very best expertise to every engagement, which will help to strengthen our commercial strategy at Research Partnership.

CEO of Research Partnership, Gareth Phillips, commented “I am delighted to congratulate Angela on her new appointment and welcome Grzegorz and Helen to the team. Angela’s expertise will be instrumental in delivering enhanced value to our clients within the European sector. Grzegorz and Helen both bring a wealth of knowledge and fresh perspectives to our dynamic workforce, and I look forward to collaborating with them both as we strengthen our Operational and Commercial capabilities across our global teams.”

Find out more and explore a range of resources at Research Partnership. 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Women’s health in emerging markets

Why can understanding and improving women’s health in emerging markets be challenging? What strategies can global pharma develop to support women and overcome these challenges? Associate Director Rachel Howard and...

Research Partnership has published a new Living with Lupus (SLE) market report for 2017

SLE is a progressive and debilitating disease which affects 5 million people worldwide.

PEGASUS AND UCL JOIN FORCES IN INSPIRING HEALTHY DECISIONS

Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed...

Cool heads in a crisis?

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

Biosimilars: Bringing patients into the conversation

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...

Pharmaceutical Market Research Conference 2017

We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.

Shifting perceptions of the use of probiotics in IBS Management

Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range...